Browse > Article
http://dx.doi.org/10.3904/kjim.2015.30.4.550

Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection  

Lee, Na-Ri (Division of Hematology and Oncology, Department of Internal Medicine, Chonbuk National University Medical School)
Jang, Ji Won (Division of Hematology and Oncology, Department of Internal Medicine, Chonbuk National University Medical School)
Kim, Hee Sun (Department of Nursing, Wonkwang University School of Medicine)
Yhim, Ho-Young (Division of Hematology and Oncology, Department of Internal Medicine, Chonbuk National University Medical School)
Publication Information
The Korean journal of internal medicine / v.30, no.4, 2015 , pp. 550-553 More about this Journal
Keywords
Lung diseases; interstitial; Imatinib mesylate; Tuberculosis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ohnishi K, Sakai F, Kudoh S, Ohno R. Twenty-seven cases of drug-induced interstitial lung disease associated with imatinib mesylate. Leukemia 2006;20:1162-1164.   DOI
2 Ma CX, Hobday TJ, Jett JR. Imatinib mesylate-induced interstitial pneumonitis. Mayo Clin Proc 2003;78:1578-1579.   DOI
3 Camus P, Bonniaud P, Fanton A, Camus C, Baudaun N, Foucher P. Drug-induced and iatrogenic infiltrative lung disease. Clin Chest Med 2004;25:479-519.   DOI
4 Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009;374:733-743.   DOI
5 Rosado MF, Donna E, Ahn YS. Challenging problems in advanced malignancy: case 3. Imatinib mesylate-induced interstitial pneumonitis. J Clin Oncol 2003;21:3171-3173.   DOI